You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).

Figure PDU-5:  Estimated trends in the prevalence of injecting drug use, 1995 to 2004 (rate per 1000 population aged 15 to 64)

Figure PDU-05

Notes:

MM = Mortality multiplier; HM = HIV multiplier; CR=Capture-recapture; TM =Treatment multiplier; TP = Truncated Poisson; CM= Combined Methods. For more details see Table PDU-1 to Table PDU-3.

Target groups may vary owing to different methods and data sources; therefore comparisons should be made with caution. The HIV multiplier may include an unknown proportion of ever injectors who are not current problem drug users. This method may thus result in higher estimates than the mortality multiplier which is based on direct drug-related mortality (overdose deaths) and thus is probably mostly limited to current injectors. In some countries data are insufficient to report. The estimates of Czech Republic refer to the age group 18-64.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

National Focal Points. See also EMCDDA project (2003): National prevalence estimates of problem drug use in the European Union, 1995–2000, CT.00.RTX.23, EMCDDA, Lisbon, coordinated by the Institut für Therapieforschung, Munich (http://www.emcdda.europa.eu/?nnodeid=1372).